Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-α convertase

Biochemical and Biophysical Research Communications

Volumn 280, Issue 3, 2001, Pages 945-950

  Lee, Meng Huee ^a   Knäuper, Vera ^a   Becherer, J David ^b   Murphy, Gillian ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

ADAM; Metalloproteinase; TIMP

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVE SITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING;

EID: 0034805593     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.4192     Document Type: Article

References (25)

1. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
2. Shedding of interleukin-6 receptor and tumor necrosis factor α: Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins
3. A novel proteolytic cleavage involved in Notch signalling: The role of the disintegrin-metalloproteinase TACE
4. Intracellular maturation and localization of the tumour necrosis factor α convertase (TACE)
5. Crystal structure of the catalytic domain of human tumour necrosis factor-α-converting enzyme
6. TNF-α converting enzyme (TACE) is inhibited by TIMP-3
7. NMR structure of tissue inhibitor of metalloproteinase-1 implicates localized induced fit in recognition of matrix metalloproteinases
8. Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 Å resolution
9. High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3
10. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase-A receptor
11. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1
12. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity
13. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A
14. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: A kinetic analysis of the inhibition of gelatinase-A
15. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family
16. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases
17. Specific sequence elements are required for the expression of functional tumor necrosis factor α-converting enzyme (TACE)
18. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: Comparison with normal bone marrow cells
19. The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations
20. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2
21. Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B
22. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A
23. Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis
24. Localisation of the death domain of TIMP-3 to the N-terminus: Metalloproteinase inhibition is associated with pro-apoptotic activity
25. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells